Gaetan Burgio of the Australian National University (Canberra, Australia) discusses the off-target effects of CRISPR, how they occur, how to avoid them and their impacts on the uses of the technique. CRISPR gene editing technology has been transformative in investigating important biological questions or studying the function of genes. Importantly the technology shows a lot of promise in improving crop or food production, and in detecting or treating diseases such as cancer, infections or severe hereditary disorders. To date, 23 active clinical trials at various stages of progression using CRISPR gene editing technology are registered in ClinicalTrials.gov. Most of the...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!